EBA'02
Sept 8-11, 2002
St. Petersburg
FL, USA

 

 

 Scientific Committee


A number of leading scientists active in the development and use of EBA
formed the Scientific Committee to plan the technical content of
EBA ´02.

 Joachim Walter (Chairman)
Boehringer Ingelheim Pharma KG, Germany
joachim.walter@bc.boehringer-ingelheim.com
Rolf Hjorth
GE Healthcare Bio-Sciences AB, Sweden
rolf.hjorth@ge.com
 
Maria-Regina Kula
University of Düsseldorf, Germany
M.-R.Kula@kfa-juelich.de
 
Rhona O’Leary
Genentech Inc, USA
oleary.rhona@gene.com
 
Jorg Thömmes
IDEC Pharmaceuticals Inc, USA
jthommes@idecpharm.com
 
Mathias Uhlén
Royal Institute of Technology, Sweden
mathias@biochem.kth.se
 
 Howard Chase
University of Cambridge, UK
hac1@cheng.cam.ac.uk
 

Executive Director
Lars-Johan Larsson,

GE Healthcare Bio-Sciences AB
S-751 84 Uppsala, Sweden
lars-johan.larsson@ge.com